BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11797301)

  • 1. Primary ophthalmic rhabdomyosarcoma in 33 patients.
    Shields CL; Shields JA; Honavar SG; Demirci H
    Trans Am Ophthalmol Soc; 2001; 99():133-42; discussion 142-3. PubMed ID: 11797301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical spectrum of primary ophthalmic rhabdomyosarcoma.
    Shields CL; Shields JA; Honavar SG; Demirci H
    Ophthalmology; 2001 Dec; 108(12):2284-92. PubMed ID: 11733272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease.
    Crist WM; Anderson JR; Meza JL; Fryer C; Raney RB; Ruymann FB; Breneman J; Qualman SJ; Wiener E; Wharam M; Lobe T; Webber B; Maurer HM; Donaldson SS
    J Clin Oncol; 2001 Jun; 19(12):3091-102. PubMed ID: 11408506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localized orbital rhabdomyosarcoma. An interim report of the Intergroup Rhabdomyosarcoma Study Committee.
    Wharam M; Beltangady M; Hays D; Heyn R; Ragab A; Soule E; Tefft M; Maurer H
    Ophthalmology; 1987 Mar; 94(3):251-4. PubMed ID: 3587902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoproliferative disease of the ocular adnexa: a clinical and pathologic study with statistical analysis of 69 patients.
    Sullivan TJ; Whitehead K; Williamson R; Grimes D; Schlect D; Brown I; Dickie G
    Ophthalmic Plast Reconstr Surg; 2005 May; 21(3):177-88. PubMed ID: 15942490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Management of Orbital Rhabdomyosarcoma in a Referral Center in Spain.
    Bravo-Ljubetic L; Peralta-Calvo J; Larrañaga-Fragoso P; Pascual NO; Pastora-Salvador N; Gomez JA
    J Pediatr Ophthalmol Strabismus; 2016; 53(2):119-26. PubMed ID: 27018885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular adnexal lymphoma staging and treatment: American Joint Committee on Cancer versus Ann Arbor.
    Graue GF; Finger PT; Maher E; Della Rocca D; Della Rocca R; Lelli GJ; Milman T
    Eur J Ophthalmol; 2013; 23(3):344-55. PubMed ID: 23397158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary ophthalmic rhabdomyosarcoma.
    Abramson DH; Sagereman R
    Ophthalmology; 2003 May; 110(5):877; author reply 877-8. PubMed ID: 12750079
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinicopathological analysis of rhabdomyosarcoma of the ocular adenexa].
    Feng G; Yi Y; Zhang J; Li Y; Zheng H; Zheng J; Lin J; Liu J; Pang Y; Wu Z
    Yan Ke Xue Bao; 1994 Jun; 10(2):125-8, 120. PubMed ID: 7843394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoproliferative diseases of the ocular adnexa in Korea.
    Oh DE; Kim YD
    Arch Ophthalmol; 2007 Dec; 125(12):1668-73. PubMed ID: 18071120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome and prognostic factors in ocular adnexal lymphoma.
    Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
    Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual outcomes and late complications in paediatric orbital rhabdomyosarcoma.
    Eade E; Tumuluri K; Do H; Rowe N; Smith J
    Clin Exp Ophthalmol; 2017 Mar; 45(2):168-173. PubMed ID: 27473389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological Features of Ocular Adnexal Mantle-Cell Lymphoma in an International Multicenter Cohort.
    Knudsen MKH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Khong JJ; McKelvie PA; Mulay K; Ralfkiaer E; Sjö LD; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
    JAMA Ophthalmol; 2017 Dec; 135(12):1367-1374. PubMed ID: 29121219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term evaluation of orbital rhabdomyosarcoma in children.
    Boutroux H; Levy C; Mosseri V; Desjardins L; Plancher C; Helfre S; Freneaux P; Cellier C; Orbach D
    Clin Exp Ophthalmol; 2015; 43(1):12-9. PubMed ID: 24923774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ophthalmic complications following treatment of paranasal sinus rhabdomyosarcoma in comparison to orbital disease.
    Gandhi PD; Fleming JC; Haik BG; Wilson MW
    Ophthalmic Plast Reconstr Surg; 2011; 27(4):241-6. PubMed ID: 21242849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary orbital melanomas: analysis of 15 cases.
    Liarikos S; Rapidis AD; Roumeliotis A; Angelopoulos AP
    J Craniomaxillofac Surg; 2000 Jun; 28(3):148-52. PubMed ID: 10964550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular adnexal follicular lymphoma: a multicenter international study.
    Rasmussen PK; Coupland SE; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; McKelvie P; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Heegaard S
    JAMA Ophthalmol; 2014 Jul; 132(7):851-8. PubMed ID: 24763920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late malignant melanoma after treatment of rhabdomyosarcoma of the orbit during childhood.
    Lumbroso L; Sigal-Zafrani B; Jouffroy T; Levy C; Rodriguez J; Desjardins L
    Arch Ophthalmol; 2002 Aug; 120(8):1087-90. PubMed ID: 12149065
    [No Abstract]   [Full Text] [Related]  

  • 19. Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study.
    Wharam MD; Meza J; Anderson J; Breneman JC; Donaldson SS; Fitzgerald TJ; Michalski J; Teot LA; Wiener ES; Meyer WH
    J Clin Oncol; 2004 May; 22(10):1902-8. PubMed ID: 15143083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
    Shields CL
    Trans Am Ophthalmol Soc; 2000; 98():471-92. PubMed ID: 11190037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.